(Source: Technical Conformance
Guide on Electronic Study Data Submissions, Pharmaceuticals and Medical
Devices Agency, Provisional Translation [as of July 2015]).
In order for the review
of clinical study data to progress smoothly, it is important that
the relationship between the analysis results shown in the application
documents and the analysis datasets is easily understandable. Therefore,
the definition documents of the ADaM datasets should preferably include
Analysis Results Metadata, which shows the relationship between the
analysis results and the corresponding analysis dataset and the variables
used, for the analyses performed to obtain the main results of efficacy
and safety and clinical study results that provide the rationales
for setting of the dosage and administration, shown in 4.1.1.3. The
Analysis Results Metadata of each analysis should preferably include
the following items.
-
Figure or table numbers and titles
showing the analysis results displayed in the clinical study report
-
Purpose and reasons for performing
the analysis
-
Parameter name and code to be
used
-
Variables subject to analysis
-
-
Selection criteria for the records
subject to analysis
-
Corresponding description in the
statistical analysis plan, analysis program name, and summary of the
analytical methods
-
Extract of the analysis program
corresponding to the analysis method
For the format of the
Analysis Results Metadata, the applicant should refer to the Analysis
Results Metadata Specification for Define-XML by CDISC to the extent
possible, but if it is difficult to include it into the definition
document, it is possible to submit it as a separated file in PDF format,
as specified in “Electronic Specifications of Common Technical
Documents”, and “Handling of Electronic Specifications
of Common Technical Documents”. The explanations in the definition
document may be written in Japanese.